TAKEDA PHARM.CO.LTD./ JP3463000004 /
| 26/07/2024 18:57:09 | Chg. +0.150 | Volume | Bid19:53:18 | Ask19:53:18 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 25.490EUR | +0.59% | 401 Turnover: 10,186.600 |
25.260Bid Size: 391 | 25.490Ask Size: 118 | 39.96 bill.EUR | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 92.09 JPY | -54.92% |
| EPS Diluted: | - JPY | -54.86% |
| Revenues per Share: | 2,717.48 JPY | 6.76% |
| Book Value per Share: | 4,635.57 JPY | 15.43% |
| Cash Flow per Share: | 456.56 JPY | -26.07% |
| Dividend per Share: | 188.00 JPY | 4.44% |
| Total | in mill. | |
| Revenues: | 4,263,762.00 JPY | 5.87% |
| Net Income: | 144,067.00 JPY | -54.56% |
| Operating Cash Flow: | 716,344.00 JPY | - |
| Cash and Cash Equivalents: | 457,800.00 JPY | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 46.10 | 45.43 |
| P/S Ratio: | 1.56 | 1.54 |
| P/BV ratio: | 0.92 | 0.90 |
| P/CF Ratio: | 9.30 | 9.16 |
| PEG: | -0.84 | -0.83 |
| Earnings Yield: | 2.17% | 2.20% |
| Dividend Yield: | 4.43% | 4.49% |
| Market Capitalization | ||
| Market Capitalization: | 39.96 bill. EUR | 39.39 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 1.57 bill. | |
Profitability
| Gross Profit Margin: | 66.54% |
| EBIT Margin: | 5.02% |
| Net Profit Margin: | 3.38% |
| Return on Equity: | 1.98% |
| Return on Assets: | 0.95% |
Financial Strength
| Liquidity I / Cash Ratio: | 19.79% |
| Liquidity II / Quick Ratio: | 48.69% |
| Liquidity III / Current Ratio: | 110.61% |
| Debt / Equity Ratio: | 107.73% |
| Dynam. Debt / Equity Ratio: | 1,093.82% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - JPY |
| Revenues / Employee: | - JPY |
| Net Income / Employee: | - JPY |
| Total Assets / Employee: | - JPY |
| * Fiscal Year End: | 31/03/2024 |
| Accounting Standard: | IFRS |
| Currency: | JPY |
